https://dengyuedistributor.com/noticias-medicas/comercializacion-de-plozasiran-sodium/ 2026-07-28T03:22:03+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/comercializacion-de-plozasiran-sodium.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/plozasiran-sodium.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/apoc3-como-nueva-diana-para-el-desarrollo-de-tratamientos-de-las-enfermedades-del-metabolismo-lipidico.webp https://dengyuedistributor.com/noticias-medicas/inhibidor-del-cfb-ciprocopan-succinate/ 2026-07-25T02:27:37+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/el-inhibidor-del-cfb-ciprocopan-succinate-recibe-la-aprobacion-para-su-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/inhibidor-del-cfb-ciprocopan-succinate.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/inhibidor-del-cfb.webp https://dengyuedistributor.com/noticias-medicas/oveporexton-recibe-la-aprobacion-para-su-comercializacion/ 2026-07-23T02:16:57+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/oveporexton-recibe-la-aprobacion-para-su-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/sintomas-de-la-narcolepsia-tipo-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/china-es-el-primer-pais-en-aprobar-oveporexton-y-demuestra-la-rapidez-de-su-sistema-de-innovacion-farmaceutica.webp https://dengyuedistributor.com/noticias-medicas/primer-anticuerpo-monoclonal-anti-il-33/ 2026-07-21T06:12:53+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/solicitud-de-autorizacion-de-comercializacion-del-primer-anticuerpo-monoclonal-anti-il-33-del-mundo-tozorakimab.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/%C2%BFpor-que-el-tratamiento-de-la-epoc-sigue-enfrentando-grandes-desafios.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/ensayos-clinicos-de-fase-iii-del-primer-anticuerpo-monoclonal-anti-il-33-del-mundo-tozorakimab.webp https://dengyuedistributor.com/noticias-medicas/agonista-dual-de-los-receptores-glp-1-gip/ 2026-07-21T03:33:41+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/el-agonista-dual-de-los-receptores-glp-1gip-ribupatide-desarrollado-de-forma-independiente-por-hengrui-pharmaceuticals-obtiene-resultados-positivos-en-un-ensayo-clinico-de-fase-iii.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/mecanismo-de-accion-de-los-agonistas-duales-de-los-receptores-glp-1gip.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/los-derechos-exclusivos-de-la-cartera-de-medicamentos-innovadores-basados-en-glp-1-incluido-ribupatide-fueron-concedidos-a-kailera-therapeutics.webp https://dengyuedistributor.com/noticias-medicas/aficamten-tablets-por-que-puede-convertirse-en-una-novedosa-seleccion-de-objetivos-para-el-tratamiento-de-la-miocardiopatia-hipertrofica-obstructiva/ 2026-07-20T03:18:55+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/miocardiopatia-hipertrofica-obstructiva.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/sintomas-de-la-miocardiopatia-hipertrofica-obstructiva.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/aficamten-tablets.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/blog/medicamentos-para-el-tratamiento-del-hiv-biktarvy-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tabletas-como-ayudar-a-los-pacientes-con-hiv-a-liberarse-de-sus-ataduras/ 2026-07-20T03:13:04+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/la-situacion-mundial-del-hiv.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-de-la-infeccion-por-hiv.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/proceso-de-aprobacion-y-lanzamiento-global-de-biktarvy.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-bictegravir-sodium-emtricitabine-and-tenofovir-alafenamide-fumarate-tabletas.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/datos-clinicos-de-biktarvy.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/guias-medicas/sintomas-tempranos-de-la-diabetes/ 2026-07-20T03:06:13+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/sintomas-tempranos-de-la-diabetes.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/que-tan-peligroso-es-no-controlar-bien-la-glucosa.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/dormir-poco-y-trasnochar-con-frecuencia.webp https://dengyuedistributor.com/blog/tratamiento-del-cancer-de-pulmon-no-microcitico/ 2026-07-20T02:57:15+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/tratamiento-del-cancer-de-pulmon-no-microcitico.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/diferencias-en-el-posicionamiento-clinico-por-diana.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/tratamiento-de-la-esclerosis-lateral-amiotrofica/ 2026-07-17T07:10:01+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/que-es-la-esclerosis-lateral-amiotrofica.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/riluzol-el-tratamiento-clasico-con-beneficio-modesto-en-supervivencia.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/edaravona-terapia-antioxidante-con-variabilidad-regional-en-la-evidencia.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/tofersen-terapia-genetica-de-precision-para-mutaciones-sod1.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/demanda-global-de-tratamiento-para-la-ela-enfoque-en-el-mercado-hispanohablante.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/noticias-medicas/aprobacion-para-la-comercializacion-de-amogammadex-sodium/ 2026-07-17T03:12:38+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/aprobacion-para-la-comercializacion-de-amogammadex-sodium.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/mecanismo-de-accion-de-amogammadex-sodium-inyectable-tras-su-aprobacion-para-la-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/multiples-lineas-de-investigacion-y-desarrollo-de-medicamentos-innovadores-de-aom-pharmaceutical.webp https://dengyuedistributor.com/noticias-medicas/gumoqimab-obtiene-la-aprobacion-de-la-nmpa/ 2026-07-17T03:01:04+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/gumoqimab-obtiene-la-aprobacion-de-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/gumoqimab.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/%C2%BFcomo-deben-gestionar-la-enfermedad-los-pacientes-con-psoriasis-de-moderada-a-grave.webp https://dengyuedistributor.com/noticias-medicas/aprobacion-de-comercializacion-de-los-comprimidos-de-succinato-de-anivecrina/ 2026-07-15T06:24:10+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/aprobacion-de-comercializacion-de-los-comprimidos-de-succinato-de-anivecrina.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/sintomas-de-la-enfermedad-de-alzheimer.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/mecanismo-de-accion-de-los-comprimidos-de-succinato-de-anivecrina.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/11-nuevas-dianas-terapeuticas-first-in-class/ 2026-07-10T06:08:56+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/novel-drug-targets-in-2025-about-11-nuevas-dianas-terapeuticas-first-in-class.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/11-nuevas-dianas-terapeuticas-first-in-class.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/el-descubrimiento-de-nuevas-dianas-originales-marcara-el-futuro-del-desarrollo-de-medicamentos.webp https://dengyuedistributor.com/noticias-medicas/cancer-de-mama-con-mutacion-esr1/ 2026-07-06T06:45:20+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/imlunestrant-recibe-la-aprobacion-de-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/cancer-de-mama-con-mutacion-esr1.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/pfs-segun-el-estado-de-comutacion-de-esr1-y-la-via-pi3k-en-todos-los-pacientes-y-en-los-pacientes-previamente-tratados-con-inhibidores-de-cdk46.webp https://dengyuedistributor.com/noticias-medicas/prevencion-del-vrs/ 2026-07-03T02:12:53+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/07/nmpa-aprueba-clesrovimab-para-la-prevencion-del-vrs.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/%C2%BFque-es-el-vrs.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/clesrovimab-un-anticuerpo-monoclonal-para-la-prevencion-de-la-infeccion-por-rsv.webp https://dengyuedistributor.com/wp-content/uploads/2026/07/el-estudio-clever-confirma-el-efecto-protector-de-clesrovimab.webp https://dengyuedistributor.com/noticias-medicas/primer-medicamento-antiinfeccioso-de-la-clase-ganan-del-mundo/ 2026-06-27T02:59:17+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/aprobacion-de-peceleganan-por-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/spray-de-peceleganan.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/ventajas-del-spray.webp https://dengyuedistributor.com/noticias-medicas/primer-anticuerpo-biespecifico-contra-la-rabia/ 2026-06-25T06:15:45+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/primer-anticuerpo-biespecifico-contra-la-rabia-aprobado-silevimig.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/virus-de-la-rabia.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/mecanismo-de-accion-del-primer-anticuerpo-biespecifico-contra-la-rabia-silevimig.webp https://dengyuedistributor.com/noticias-medicas/terapia-car-t-dirigida-a-cldn18-2/ 2026-06-24T06:40:59+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/nmpa-aprueba-la-terapia-car-t-dirigida-a-cldn18.2-satricabtagene-autoleucel-obtiene-autorizacion-de-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/terapia-car-t-dirigida-a-cldn18.2-satricabtagene-autoleucel.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/diseno-del-ensayo-clinico-de-satricabtagene-autoleucel.webp https://dengyuedistributor.com/blog/primer-medicamento-protac-del-mundo/ 2026-06-24T01:33:14+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/veppanu-habia-obtenido-la-aprobacion-de-la-fda.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/%C2%BFque-es-la-tecnologia-protac.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/tecnologia-de-degradacion-de-proteinas.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/dengyue-pharma-%E2%80%94-basada-en-el-ecosistema-global-de-medicamentos-innovadores-conecta-tecnologias-de-vanguardia-con-recursos-industriales-estrategicos.webp https://dengyuedistributor.com/noticias-medicas/el-primer-adc-biespecifico-del-mundo/ 2026-06-23T03:20:45+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/aprobacion-de-izalontamab-brengitecan-por-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/las-dianas-terapeuticas-del-primer-adc-biespecifico-del-mundo.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/datos-clinicos-de-izalontamab-brengitecan.webp https://dengyuedistributor.com/blog/mutacion-kras-cancer-de-pancreas-asco-2026/ 2026-06-17T03:17:05+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/sintomas-del-cancer-de-pancreas.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/estudio-destacado-de-asco-2026-i-daraxonrasib-rmc-6236-logra-una-cobertura-pan-ras.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/%C2%BFpor-que-los-pacientes-con-cancer-de-pancreas-deben-realizarse-pruebas-geneticas-de-kras.webp https://dengyuedistributor.com/noticias-medicas/conteltinib-obtiene-la-aprobacion-de-la-nmpa-para-nsclc-alk-positivo/ 2026-06-15T06:57:59+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/conteltinib-obtiene-la-aprobacion-de-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/medicamento-en-granulos.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/dengyue-a-la-vanguardia-de-la-innovacion-farmaceutica-global-integrando-informacion-internacional-sobre-nuevos-medicamentos-y-avances-en-medicina-de-precision.webp https://dengyuedistributor.com/blog/es-seguro-el-uso-off-label-de-medicamentos/ 2026-06-13T03:46:26+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/es-seguro-el-uso-off-label-de-medicamentos.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/uso-off-label-de-medicamentos-para-el-tratamiento-de-enfermedades-neurodegenerativas.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/%C2%BFcomo-respalda-la-evidencia-medica-el-uso-off-label-de-medicamentos.webp https://dengyuedistributor.com/noticias-medicas/lanoracopan-recibe-aprobacion-para-el-tratamiento-de-la-hpn/ 2026-06-12T06:21:32+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/lanoracopan-recibe-aprobacion-para-el-tratamiento-de-la-hpn.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/como-es-el-panorama-actual-del-tratamiento-de-la-hpn-los-inhibidores-del-complemento-estan-cambiando-el-pronostico-de-los-pacientes.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/perfil-de-seguridad-generalmente-favorable.webp https://dengyuedistributor.com/noticias-medicas/rocbrutinib-recibe-la-aprobacion-oficial/ 2026-06-11T06:04:21+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/arocbrutinib-recibe-la-aprobacion-oficial.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/sintomas-del-linfoma-de-celulas-del-manto.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/los-medicamentos-innovadores-continuan-mejorando-el-panorama-del-tratamiento-de-los-tumores-hematologicos.webp https://dengyuedistributor.com/blog/33-nuevos-medicamentos-aprobados-mayo-2026/ 2026-06-05T06:44:03+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/mantente-al-dia-con-las-ultimas-novedades-sobre-nuevos-medicamentos-en-china-y-el-extranjero.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/lanzamiento-de-nuevos-medicamentos.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/por-que-la-tecnologia-medica-china-atrae-pacientes-internacionales/ 2026-06-04T07:40:35+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/ayuda-a-los-pacientes-internacionales-a-conocer-mejor.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/diagnostico-asistido-por-inteligencia-artificial.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/robot-inteligente-para-orientacion-medica.webp https://dengyuedistributor.com/guias-medicas/mejor-destino-medico-para-pacientes-internacionales/ 2026-06-03T03:40:30+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/ayudamos-a-elegir-el-mejor-destino-medico-para-pacientes-internacionales.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/la-innovacion-farmaceutica-en-china-avanza-rapidamente.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/dengyue-le-ayuda-a-encontrar-el-mejor-destino-medico-para-usted.webp https://dengyuedistributor.com/noticias-medicas/anbenitamab-recibe-la-aprobacion-para-su-comercializacion-her2-positivo/ 2026-06-02T06:14:40+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/06/anbenitamab-recibe-la-aprobacion-para-su-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/clasificacion-del-cancer-gastrico.webp https://dengyuedistributor.com/wp-content/uploads/2026/06/diana-terapeutica-her2.webp https://dengyuedistributor.com/blog/crisis-mundial-de-medicamentos-falsificados/ 2026-05-29T09:10:39+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/crisis-mundial-de-medicamentos-falsificados.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/codigo-de-trazabilidad-farmaceutica.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/etiqueta-antifalsificacion-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/distribuidor-farmaceutico-dengyuepharma.webp https://dengyuedistributor.com/guias-medicas/medicamentos-de-canales-no-oficiales/ 2026-05-28T07:47:10+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/rechace-los-medicamentos-provenientes-de-canales-no-oficiales.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/licencias-y-certificaciones-farmaceuticas-oficiales.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/dengyue-pharma-distribuidor-farmaceutico-global-legal-y-autorizado.webp https://dengyuedistributor.com/blog/proveedores-globales-de-peptidos-de-retatrutide/ 2026-05-26T09:33:49+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/el-efecto-de-perdida-de-peso-de-retatrutide.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/proveedores-globales-de-peptidos-de-retatrutide.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/la-cadena-global-de-suministro-de-peptidos-de-retatrutide-de-dengyue-pharma.webp https://dengyuedistributor.com/noticias-medicas/tratamiento-de-la-gota/ 2026-05-23T09:08:18+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/nmpa-aprueba-firsekibart-en-formulacion-liquida-para-el-tratamiento-de-la-gota.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/mecanismo-de-accion-de-firsekibart-en-formulacion-liquida-para-el-tratamiento-de-la-gota.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/sintomas-de-la-gota.webp https://dengyuedistributor.com/noticias-medicas/medicamento-innovador-mejorado-de-china-bcm335-fda/ 2026-05-21T08:11:25+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/medicamentos-innovadores-mejorados-de-china-bcm335-recibe-aceptacion-de-la-fda.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/regiones-patentadas-de-medicamentos-innovadores-mejorados-de-china-bcm335.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/formulaciones-RTU.webp https://dengyuedistributor.com/noticias-medicas/primer-anticuerpo-pd-l1-subcutaneo-del-mundo/ 2026-05-19T09:09:06+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/la-solicitud-de-comercializacion-de-una-nueva-indicacion-de-envafolimab-el-primer-medicamento-anticuerpo-pd-l1-subcutaneo-del-mundo-ha-sido-oficialmente-aceptada.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/envafolimab-primer-medicamento-anticuerpo-pd-l1-subcutaneo-del-mundo.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/inyeccion-subcutanea.webp https://dengyuedistributor.com/noticias-medicas/primer-car-t-para-tumores-solidos-china-cancer-gastrico/ 2026-05-15T07:16:41+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/primer-CAR-T-para-tumores-solidos-del-mundo-Satricabtagene-autoleucel-Satri-celCT041.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/datos-de-estudios-clinicos-del-primer-car-t-para-tumores-solidos.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/primer-car-t-para-tumores-solidos-para-el-tratamiento-del-cancer-gastrico.webp https://dengyuedistributor.com/blog/tratamiento-contra-el-cancer-en-china/ 2026-05-14T07:55:06+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/desarrollo-del-tratamiento-contra-el-cancer-en-China.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/hospitales-de-tratamiento-contra-el-cancer-en-China.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/guias-medicas/hospitales-oncologicos-certificados-por-jci-en-china/ 2026-05-12T08:34:06+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/Uno-de-los-hospitales-oncologicos-certificados-por-JCI-en-China-Hospital-Oncologico-RoyalLee-de-Guangzhou.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/Hospital-Oncologico-de-Hunan-Afiliado-a-Xiangya.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/Hospital-de-Protones-y-Iones-Pesados-de-Shanghai.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/Hospital-Oncologico-Fuda-de-Guangzhou.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/Hospital-Moderno-del-Cancer-de-Guangzhou.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/dengyuepharma-reune-recursos-medicos-globales-para-proteger-cada-esperanza-de-vida.webp https://dengyuedistributor.com/blog/tratamiento-linfoma-difuso-celulas-b-grandes-recaida-refractario/ 2026-05-09T09:14:35+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/linfoma-difuso-de-celulas-B-grandes-en-recaida-o-refractario.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/equecabtagene-autoleucel-para-el-tratamiento-del-linfoma-de-celulas-b-grandes-recidivanterefractario.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/tafasitamab-y-lenalidomida-en-terapia-combinada-para-linfoma-de-celulas-b-grandes-recidivanterefractario.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/como-se-diagnostica-el-linfoma-difuso-de-celulas-b-grandes-en-recaida-o-refractario.webp https://dengyuedistributor.com/blog/terapia-celular-y-genica/ 2026-05-08T07:28:12+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/que-es-la-terapia-celular-y-genica.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/IA-y-digitalizacion-impulsan-la-ID.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/Hong-Kong-Dengyue-Pharma.webp https://dengyuedistributor.com/noticias-medicas/mutacion-egfr-exon-20-pulmon/ 2026-05-07T09:01:13+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/05/andamertinib-aprobado-por-la-NMPA-para-su-comercializacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/mutacion-egfr-exon-20-pulmon.webp https://dengyuedistributor.com/wp-content/uploads/2026/05/los-medicamentos-innovadores-chinos-impulsan-el-tratamiento-de-la-mutacion-por-insercion-en-el-exon-20-del-EGFR.webp https://dengyuedistributor.com/blog/terapia-car-t-dirigida-a-bcma-mieloma-multiple/ 2026-04-30T06:49:22+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/mieloma-multiple.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/mecanismo-central-de-la-terapia-CAR-T-dirigida-a-BCMA.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/CAR-T-de-doble-diana-nueva-tendencia.webp https://dengyuedistributor.com/blog/10-terapias-innovadoras-2026-tendencias-medicas-avanzadas/ 2026-04-25T08:19:30+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/inteligencia-artificial.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/anticuerpos-conjugados-con-farmacos-ADC-eje-clave-de-las-10-terapias-innovadoras.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/terapia-de-edicion-genetica-CRISPR-del-laboratorio-a-la-clinica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/noticias-medicas/sevabertinib-inhibidor-de-tirosina-quinasa-nsclc-her2-china/ 2026-04-23T09:01:33+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/la-nmpa-aprueba-el-lanzamiento-al-mercado-de-sevabertinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/mecanismo-de-accion-de-sevabertinib.webp https://dengyuedistributor.com/noticias-medicas/terapia-sctil-pionera-a-nivel-mundial-avance-inmunoterapia-cancer/ 2026-04-21T08:54:59+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/mecanismo-de-accion-como-la-terapia-ScTIL-pionera-a-nivel-mundial-mejora-la-capacidad-antitumoral.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cancer-immunology-research.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/datos-clave-aumento-de-supervivencia-en-cancer-biliar.webp https://dengyuedistributor.com/noticias-medicas/5-terapias-innovadoras-clave-enfermedades-raras-2026/ 2026-04-17T08:23:59+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/un-grupo-representativo-de-5-terapias-innovadoras-clave-se-encuentra-en-etapas-clinicas-criticas-y-ha-demostrado-el-potencial-de-transformar-el-panorama-terapeutico.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cancer-de-pancreas.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/dermatomiositis.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/un-nuevo-objetivo-multiples-defensas-ripretinib-abre-un-nuevo-capitulo-en-el-tratamiento-del-gist-avanzado/ 2026-04-17T01:53:04+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/qinclock-ripretinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-del-gist.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-del-ripretinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-del-ripretinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/4-investigaciones-destacadas-cancer-pulmon-avanzado-aacr-2026/ 2026-04-16T08:22:20+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/cancer-de-pulmon-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/una-de-las-4-investigaciones-destacadas-en-cancer-de-pulmon-avanzado-elisrasib-y-la-inhibicion-precisa-de-KRAS-g12c.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/segunda-de-las-4-investigaciones-destacadas-en-cancer-de-pulmon-avanzado-stk-012-y-nuevas-soluciones-frente-a-la-resistencia-inmunologica.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cuarta-de-las-4-investigaciones-destacadas-en-cancer-de-pulmon-avanzado-zl-1310-y-el-avance-en-cancer-de-pulmon-de-celulas-pequenas.webp https://dengyuedistributor.com/blog/3-dianas-prioritarias-de-los-adc/ 2026-04-14T08:49:27+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/3-dianas-prioritarias-de-los-adc.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/claudin-18.2-representante-de-alta-especificidad-entre-las-3-dianas-prioritarias-de-los-adc.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/b7-h3-una-diana-con-potencial-de-amplio-espectro-entre-las-3-principales-dianas-de-los-adc.webp https://dengyuedistributor.com/blog/primer-farmaco-biespecifico-dll3-cd3-analisis-mercado-global/ 2026-04-11T09:00:22+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/primer-farmaco-biespecifico-dll3cd3-%E2%80%94-tarlatamab-%E2%80%94-ha-sido-aprobado-para-su-comercializacion-en-China.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/innovacion-del-mecanismo-del-anticuerpo-dll3cd3.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/expansion-del-campo-de-los-anticuerpos-biespecificos.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cadena-de-suministro-y-circulacion-global.webp https://dengyuedistributor.com/noticias-medicas/nuevos-farmacos-adc-innovacion-oncologia/ 2026-04-10T09:03:36+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/la-empresa-emergente-de-biotecnologia-Stipple-Bio-anuncio-recientemente-la-finalizacion-exitosa-de-una-ronda-de-financiacion-de-aproximadamente-100-millones-de-dolares.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/nuevos-farmacos-ADC-entran-en-una-fase-clinica-clave.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/de-la-id-a-la-comercializacion-la-capacidad-integral-se-vuelve-clave.webp https://dengyuedistributor.com/blog/oportunidades-de-inversion-farmaceutica-2026/ 2026-04-08T09:00:05+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/oportunidades-de-inversion-farmaceutica.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/medicina-y-tecnologia-de-ia.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cadena-de-suministro-de-la-industria-farmaceutica.webp https://dengyuedistributor.com/noticias-medicas/terapia-genica-viral-basada-en-aav-fda-avance-medicina-curativa/ 2026-04-03T08:46:58+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/terapia-genica-viral-basada-en-aav-obtiene-designacion-de-terapia-innovadora-por-la-fda.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/mecanismo-de-accion-de-la-terapia-genica-viral-basada-en-aav.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/desafios-de-industrializacion-y-panorama-competitivo-global.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/globales-como-dengyuepharma-desempenan.webp https://dengyuedistributor.com/noticias-medicas/terapia-acc-nk-para-cancer-fase-2-cancer-pulmon/ 2026-04-02T08:48:08+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/aprobacion-implicita-de-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/cancer-de-pulmon.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/%C2%BFque-es-la-terapia-acc-nk-para-cancer-una-nueva-via-en-terapias-celulares.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/hongkong-dengyuepharma.webp https://dengyuedistributor.com/noticias-medicas/terapia-celular-til-inmunoterapia-cancer-tratamiento/ 2026-04-02T02:25:51+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/04/que-es-la-terapia-TIL-y-por-que-se-ha-convertido-en-una-tendencia-clave.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/analisis-de-los-datos-clinicos-de-GC101-%C2%BFque-significa-una-tasa-del-417.webp https://dengyuedistributor.com/wp-content/uploads/2026/04/junshi-biosciences.webp https://dengyuedistributor.com/guias-medicas/guia-adquisicion-online-medicamentos-chinos-importacion/ 2026-03-27T08:47:23+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/dengyue-pharma-un-mayorista-farmaceutico-global.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/crecimiento-de-la-demanda-global-de-adquisicion-online-de-medicamentos-chinos-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/la-digitalizacion-y-la-cooperacion-global-impulsan-la-evolucion-del-modelo.webp https://dengyuedistributor.com/blog/plataforma-global-de-cooperacion-medica/ 2026-03-26T09:02:08+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/documentos-de-cumplimiento-de-dengyuepharma.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/plataforma-digital-de-dengyuepharma.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/about-dengyuepharma.webp https://dengyuedistributor.com/guias-medicas/compra-transfronteriza-de-medicamentos-cumplimiento-logistica/ 2026-03-24T09:00:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/auditoria-rigurosa-de-los-canales-de-suministro.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/gestion-logistica-y-cadena-de-frio.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/conclusion-y-perspectivas-futuras-hacia-un-ecosistema-de-adquisicion-conforme-mas-eficiente.webp https://dengyuedistributor.com/blog/terapia-dirigida-a-her2-mecanismo-y-farmacos/ 2026-03-20T09:14:26+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/que-es-her2-y-como-influye-su-via-de-senalizacion-en-el-desarrollo-del-cancer.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/trastuzumab-y-pertuzumab.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-los-adc-en-la-terapia-dirigida-a-her2.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/mecanismo-de-anticuerpos-biespecificos-pd1-ctla4-inmunoterapia/ 2026-03-18T09:30:45+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/inmunoterapia.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-accion-del-anticuerpo-biespecifico-PD-1-CTLA-4.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-accion-del-anticuerpo-biespecifico-PD-1-CTLA-4-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/farmacos-de-inmunoterapia.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/mecanismo-de-accion-de-los-farmacos-adc/ 2026-03-17T09:08:03+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/como-funciona-el-mecanismo-de-accion-de-los-farmacos-adc.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-accion-de-los-farmacos-ADC-research-paper.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-accion-de-los-farmacos-ADC.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/noticias-medicas/anticuerpo-trispecifico-ak150-inmunoterapia-cancer/ 2026-03-14T09:04:54+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/anticuerpo-trispecifico-ak150-ha-sido-aprobado-para-ensayos-clinicos-por-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/anticuerpo-trispecifico.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/pipeline-medicamentos-innovadores-china/ 2026-03-13T01:56:02+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/pipeline-farmaceutico-de-chia-tai-tianqing.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/anticuerpos-biespecificos.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/enfermedades-metabolicas.webp https://dengyuedistributor.com/blog/15-medicamentos-innovadores-contra-el-cancer/ 2026-03-10T09:10:57+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/tipos-de-acciones-de-los-fmedicamentos-innovadores-contra-el-cancer.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/tumores-solidos-se-convierten-en-el-nuevo-campo-de-batalla.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/los-medicamentos-innovadores-chinos-se-estan-globalizando.webp https://dengyuedistributor.com/noticias-medicas/amdokitug-injection-nmpa-approval-plaque-psoriasis/ 2026-03-06T09:15:06+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/nmpa-aprueba-la-amdokitug-injection.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/que-es-la-psoriasis-en-placas.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/mecanismo-de-accion-de-amdokitug-injection-bloqueo-de-la-via-inflamatoria-il-17a.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/10-innovacion-farmaceutica-china-a-seguir-en-2026/ 2026-03-05T09:03:10+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/03/antibody-drug-conjugates.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/inhibidores-de-pd-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/03/terapia-celular-CAR-T.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/perspectivas-futuras-de-los-mayoristas-farmaceuticos-globales-5-tendencias-clave-para-2026/ 2026-02-28T09:00:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/dengyue-pharma-un-mayorista-farmaceutico-global.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/modelos-de-distribucion-directa-a-proveedores-sanitarios.webp https://dengyuedistributor.com/blog/como-el-acceso-al-mercado-esta-redefiniendo-la-exportacion-farmaceutica-de-china-al-mundo/ 2026-02-27T08:25:54+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/la-vision-de-dengyuepharma-sobre-la-exportacion-farmaceutica.webp https://dengyuedistributor.com/blog/distribuidores-y-proveedores-farmaceuticos-de-china-guia-de-socios-confiables-2026/ 2026-02-26T03:15:46+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/por-que-son-tan-importantes-los-proveedores-farmaceuticos-confiables.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/proveedores-farmaceuticos-de-China-hongkongdengyuepharma.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/certificados-de-dengyue-pharma.webp https://dengyuedistributor.com/blog/analisis-en-profundidad-del-mercado-mundial-de-enfermedades-hematologicas-raras-y-biologicos-en-2026/ 2026-02-14T08:58:16+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/mercado-mundial-de-la-hemofilia.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/mercado-de-hpn-e-inhibidores-del-complemento.webp https://dengyuedistributor.com/blog/como-cambia-el-inhibidor-de-il-17a-secukinumab-cosentyx-las-reglas-del-manejo-de-la-inflamacion/ 2026-02-11T06:56:33+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-secukinumab.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/secukinumab-inyeccion-cosentyx.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/que-es-la-artritis-psoriasica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/que-es-la-hidradenitis-supurativa.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/pronostico-del-mercado-de-secukinumab.webp https://dengyuedistributor.com/blog/mercado-global-del-tratamiento-de-la-hemofilia/ 2026-02-10T09:03:36+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/comparacion-de-cuatro-terapias-clave-desde-el-reemplazo-de-factores-hasta-las-terapias-no-basadas-en-factores.webp https://dengyuedistributor.com/blog/como-elegir-los-farmacos-de-la-familia-de-los-taxanos/ 2026-02-08T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/panoramica-de-los-cuatro-principales-farmacos-de-la-familia-de-los-taxanos.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/caracteristicas-de-los-mecanismos-de-accion-de-los-4-derivados-de-paclitaxel.webp https://dengyuedistributor.com/blog/5-grandes-agentes-alquilantes-panorama-de-ventas-impulsado-por-la-poblacion-de-pacientes-y-analisis-del-mercado/ 2026-02-23T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/ciclofosfamida-ifosfamida-melfalan-clorambucilo-y-busulfan.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/mieloma-multiple.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/valor-de-mercado-mundial-del-clorambucilo.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/farmacos-antineoplasicos-en-los-mercados-hispanohablantes/ 2026-02-21T09:03:39+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/02/analisis-clinico-y-comercial-de-carmustina-lomustina-temozolomida-tiotepa-y-metotrexato.webp https://dengyuedistributor.com/wp-content/uploads/2026/02/valor-del-mecanismo-de-dano-del-adn-de-los-agentes-alquilantes.webp https://dengyuedistributor.com/blog/tratamiento-con-inmunoterapia-pd-1-penpulimabanniko-y-su-valor-clinico/ 2026-02-19T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/penpulimab-inyeccion-anniko.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-penpulimab-en-el-tratamiento-con-inmunoterapia-pd-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/datos-experimentales-sobre-penpulimab-en-el-carcinoma-nasofaringeo.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/penpulimab-recibe-la-aprobacion-de-la-fda.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/tratamiento-innovador-para-la-leucemia-con-mutacion-t315i-ponatinib-iclusig/ 2026-02-17T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/contexto-fisiopatologico-de-la-indicacion.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/ponatinib-Iclusig.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-ponatinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/evidencia-clinica-de-ponatinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/descubriendo-el-mecanismo-del-tratamiento-con-inhibidores-de-pd-l1-para-el-cancer-de-pulmon-de-celulas-pequenas-como-activa-adebrelimab-airuili-el-sistema-inmunitario/ 2026-02-15T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/cancer-de-pulmon-de-celulas-pequenas-sclc.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/adebrelimab-airuili.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-adebrelimab.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/datos-clinicos-de-adebrelimab.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/como-darzalex-faspro-hace-que-el-tratamiento-del-mieloma-multiple-sea-menos-doloroso-5-horas-de-goteo-intravenoso-frente-a-3-minutos-de-inyeccion/ 2026-02-13T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/definicion-y-sintomas-del-mieloma-multiple.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/definicion-y-sintomas-de-la-amiloidosis-primaria-de-cadenas-ligeras.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-darzalex-faspro.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-de-darzalex-faspro-en-espana-america-latina-y-el-mundo.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/darzalex-faspro.webp https://dengyuedistributor.com/blog/explicacion-detallada-del-mecanismo-de-accion-de-ixekizumab-taltz-la-via-desde-il-17a-hasta-el-bloqueo-de-la-inflamacion/ 2026-02-09T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/ixekizumab-taltz.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-ixekizumab.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/evidencia-clinica-de-ixekizumab-tratamiento-de-la-espondilitis-anquilosante-y-la-psoriasis.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/huella-global-de-ixekizumab.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/como-pueden-los-pacientes-con-caquexia-por-cancer-ganar-peso-rapidamente-revelan-datos-clinicos-del-megestrol-acetate/ 2026-02-07T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/megestrol-acetate.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/progesterona-sintetica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-del-megestrol-acetate.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/csco.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/analisis-detallado-del-mecanismo-de-accion-de-rezvilutamide-airuien-evidencia-clinica-muestra-una-reduccion-del-54-en-el-riesgo-de-progresion-de-la-enfermedad/ 2026-02-05T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/airuien-rezvilutamide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cancer-de-prostata.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-rezvilutamide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/evidencia-clinica-de-rezvilutamide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/analisis-del-mecanismo-de-accion-de-dalpiciclib-inhibidor-de-cdk4-6-como-inhibe-dalpiciclib-airuikang-las-celulas-cancerosas/ 2026-02-03T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/dalpiciclib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-dalpiciclib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-del-mercado-global-de-dalpiciclib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/nuevos-avances-en-el-tratamiento-del-cancer-de-pulmon-20-nuevos-medicamentos-6-tecnologias-inmunologicas-innovadoras-atacando-con-precision-8-objetivos-clave/ 2026-02-01T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/tratamiento-del-cancer-de-pulmon.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/rompiendo-el-dilema-de-la-resistencia-a-los-inhibidores-de-cdk4-6-por-que-se-ha-convertido-el-abemaciclibverzenios-en-la-opcion-preferida-para-el-tratamiento-del-cancer-de-mama/ 2026-01-30T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/abemaciclib-1.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-del-verzenios.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/evidencia-clinica-de-abemaciclib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/adempas-riociguat-como-activar-sgc-para-tratamiento-de-la-hipertension-pulmonar/ 2026-01-28T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/adempas-riociguat-tableta.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/hipertension-pulmonar-causas-y-sintomas-explicados.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/guanilato-ciclasa-soluble-sgc.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-de-riociguat.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/navelbine-vinorelbine-tartrate-por-que-este-farmaco-antitumoral-nicho-permite-que-algunos-pacientes-con-cancer-de-pulmon-avanzado-vivan-3-anos-mas/ 2026-01-26T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/navelbine-vinorelbine-tartrate-2.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/evidencia-clinica-aprobada.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/tubulina.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/analisis-de-los-11-medicamentos-innovadores-mas-vistos-a-nivel-mundial-en-2026-tendencias-clave-en-la-industria-farmaceutica/ 2026-01-24T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/retatrutide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/conclusion-La-innovacion-impulsa-el-futuro-medico.webp https://dengyuedistributor.com/blog/una-revolucion-en-el-tratamiento-de-la-obesidad-y-la-diabetes-tipo-2-en-2026-como-orforglipron-y-retatrutide-revolucionaran-el-manejo-de-las-enfermedades-metabolicas/ 2026-01-22T06:30:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/segun-datos-de-la-who-de-2025.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/orforglipron.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/retatrutide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/perspectivas-del-mercado.webp https://dengyuedistributor.com/blog/mejora-de-la-seguridad-renal-de-los-medicamentos-para-la-hepatitis-b-cronica-como-protege-tenofovir-amibufenamide-la-salud-futura-de-su-higado/ 2026-01-20T07:35:25+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/hengmu-tenofovir-amibufenamida.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/la-situacion-global-de-la-hepatitis-b-cronica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-de-la-hepatitis-b-cronica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-tenofovir-amibufenamide.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-de-tenofovir-amibufenamide.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/fruquintinib-un-inhibidor-de-vegfr-para-medicamentos-contra-el-cancer-de-recto-que-bloquea-la-angiogenesis-tumoral/ 2026-01-14T08:56:35+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/cancer-de-recto.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/tratamiento-cancer-de-recto.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/fruquintinib-recibe-la-aprobacion-de-la-fda.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-fruquintinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-del-fruquintinib.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/epidaza-chidamida-inhibidor-de-hdac-el-pintor-de-genes-de-las-celulas-cancerosas/ 2026-01-18T06:24:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/epidaza-chidamida.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cual-es-la-evidencia-clinica-correspondiente-a-la-nueva-indicacion-aprobada.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-la-chidamida.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-de-la-chidamida.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/el-secreto-del-tebiao-recombinant-human-thrombopoietin-por-que-es-un-revolucionario-en-el-tratamiento-de-la-trombocitopenia/ 2026-01-12T01:03:29+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-de-la-trombocitopenia.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/lanzamiento-de-la-tebiao.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/nuevas-indicaciones-de-la-tebiao.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-tebiao.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-de-la-rhtpo.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/cadena-de-suministro-farmaceutica-de-china-dengyuepharma.webp https://dengyuedistributor.com/blog/qinganxin-avatrombopag-un-salvador-para-el-tratamiento-medicamentos-para-la-trombocitopenia-en-la-enfermedad-hepatica-cronica/ 2026-01-08T01:05:16+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/qinganxin-avatrombopag.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/contexto-global-de-la-enfermedad-hepatica-cronica-y-la-trombocitopenia.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-de-la-trombocitopenia-en-las-enfermedades-hepaticas.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismos-fisiopatologicos-de-la-trombocitopenia-en-enfermedades-hepaticas-cronicas.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-de-avatrombopag.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-global-de-avatrombopag.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/blog/orelabrutinib-una-nueva-esperanza-en-el-tratamiento-de-la-enfermedad-proliferativa-maligna-linfocitica/ 2026-01-04T09:38:14+00:00 https://dengyuedistributor.com/wp-content/uploads/2026/01/sintomas-relacionados-con-la-enfermedad.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/situacion-global-tratamiento-de-la-enfermedad-proliferativa-maligna-linfocitica.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/orelabrutinib-aprobacion-por-la-nmpa.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/mecanismo-de-accion-del-orelabrutinib.webp https://dengyuedistributor.com/wp-content/uploads/2026/01/valor-de-mercado-en-el-campo-global-del-tratamiento-de-la-enfermedad-proliferativa-maligna-linfocitica.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20251117172954_207_39.webp https://dengyuedistributor.com/blog/saibeixin-pazopanib-un-rayo-de-esperanza-para-los-medicamentos-para-el-carcinoma-de-celulas-renales/ 2025-12-31T08:25:17+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/carcinoma-de-celulas-renales.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-de-Pazopanib.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/impacto-en-el-tratamiento-global-del-carcinoma-de-celulas-renales.webp https://dengyuedistributor.com/blog/un-gran-avance-en-el-tratamiento-de-tumores-avanzados-las-tabletas-de-qingweishi-everolimus-han-sido-aprobadas-para-su-comercializacion-abriendo-un-nuevo-capitulo-en-el-tratamiento-dirigido/ 2025-12-31T02:51:38+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/esquemas-clave-de-tratamiento-de-linea-posterior-que-cubren-multiples-tipos-de-tumores.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-del-everolimus.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/remodelando-el-panorama-del-tratamiento-tumoral-destacando-la-fuerza-farmaceutica-china.webp https://dengyuedistributor.com/blog/por-que-glumetinib-se-ha-convertido-en-un-avance-global-en-medicamentos-para-el-tratamiento-del-nsclc/ 2025-12-29T09:52:40+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/medicamentos-para-el-tratamiento-del-nsclc.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/sintomas-del-nsclc.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-del-glumetinib.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/la-importancia-global-del-lanzamiento-de-glumetinib.webp https://dengyuedistributor.com/noticias-medicas/pimicotinib-hydrochloride-obtiene-aprobacion-en-china-un-hito-global-para-el-tratamiento-del-tumor-de-celulas-gigantes-de-la-vaina-tendinosa/ 2025-12-29T03:06:55+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/la-nmpa-aprueba-el-clorhidrato-de-pimicotinib-para-su-lanzamiento-al-mercado.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/sintomas-del-tumor-de-celulas-gigantes-de-la-vaina-tendinosa.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-del-pimicotinib-hydrochloride.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/blog/tratamiento-de-enfermedades-inmunitarias-sistemicas-la-terapia-de-doble-objetivo-de-telitacicept-rompe-moldes/ 2025-12-26T01:35:24+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/enfermedades-inmunitarias-sistemicas.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/telitacicept.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/miastenia-gravis.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/nejm.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/noticias-medicas/una-revolucion-en-el-nefropatia-por-iga-tratamento-como-las-terapias-dirigidas-estan-cambiando-el-destino-de-los-pacientes/ 2025-12-25T02:21:15+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/que-e-nefropatia-por-iga.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/que-causa-nefropatia-por-iga.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/sintomas-de-nefropatia-por-iga.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/nefropatia-por-iga-diagnostico.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/medicamentos-para-el-tratamiento-de-la-nefropatia-por-iga.webp https://dengyuedistributor.com/noticias-medicas/apuntando-a-la-antitrombina-fitusiran-sodico-un-medicamentos-para-la-hemofilia-se-lanza-en-china/ 2025-12-23T08:22:10+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/hemofilia.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/sintomas-varian-segun-la-gravedad.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/fitusiran-sodium-injection.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global.webp https://dengyuedistributor.com/noticias-medicas/lanzamiento-de-culmerciclib-capsules-una-nueva-era-en-el-tratamiento-del-cancer-de-mama/ 2025-12-22T08:17:12+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/la-NMPA-ha-dado-oficialmente-su-aprobacion-al-lanzamiento-de-culmerciclib-capsules.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/culmerciclib-capsules.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/conocer-los-cancer-de-mama-sintomas.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/el-tratamiento-del-cancer-de-mama.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/DengYuePharma.webp https://dengyuedistributor.com/blog/un-nuevo-objetivo-la-molecula-il-25-de-china-esta-impulsando-el-desarrollo-del-mercado-farmaceutico-de-china-y-creando-oportunidades-globales/ 2025-12-19T10:07:19+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/conectando-la-innovacion-local-con-el-mercado-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/license-out.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/exploracion-de-nuevos-blancos-y-nuevos-mecanismos-espacio-para-mejora-y-oportunidades-de-innovacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/noticias-medicas/que-hay-detras-del-pequeno-exito-de-los-medicamentos-innovadores-en-china-verificacion-del-desarrollo-farmaceutico/ 2025-12-18T08:59:04+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/creando-nuevas-posibilidades-para-la-colaboracion-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/estrechando-la-brecha-con-el-exterior.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/crecimiento-del-porcentaje-global-de-ensayos-clinicos.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/farmacos-innovadores-chinos-liderazgo-global-en-evolucion-y-su-impulso-multiple/ 2025-12-17T07:49:40+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/valle-de-la-medicina-china.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/el-sector-cxo-motor-invisible-de-la-industria-farmaceutica-china.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/impulso-cientifico-y-financiero-base-solida-para-el-crecimiento.webp https://dengyuedistributor.com/noticias-medicas/una-revolucion-en-los-medicina-para-la-gripe-se-lanzan-las-capsulas-de-pixavir-marboxil/ 2025-12-16T06:24:15+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/el-virus-de-la-influenza-se-convierte-en-una-amenaza-global-para-la-salud-publica.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/virus.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/medicina-china-para-la-gripe.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-de-las-capsulas-de-pixavir-marboxil.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global.webp https://dengyuedistributor.com/noticias-medicas/el-lanzamiento-de-picankibart-ha-redefinido-las-opciones-de-tratamiento-para-la-psoriasis-en-placas/ 2025-12-15T08:44:04+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/picankibart.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/que-es-psoriasis-en-placas-y-cuales-son-sus-caracteristicas-clave.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/una-nueva-era-en-china.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-de-picankibart.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E6%9C%AA%E5%91%BD%E5%90%8D%E7%9A%84%E8%AE%BE%E8%AE%A1-15.png https://dengyuedistributor.com/noticias-medicas/el-inhibidor-de-trk-de-nueva-generacion-zurletrectinib-ha-sido-aprobado-en-china-lo-que-brinda-esperanza-a-los-pacientes-con-ntrk-fusion/ 2025-12-15T02:36:53+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/zurletrectinib.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/validacion-clinica.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-1.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/noticias-medicas/la-epoc-se-puede-curar-todo-lo-que-debes-saber-sobre-la-enfermedad-pulmonar-obstructiva-cronica/ 2025-12-12T09:55:34+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/cpod.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/epoc-sintomas.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/causas-de-la-epoc.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/evidencia-clinica.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/image-30.png https://dengyuedistributor.com/noticias-medicas/lanzamiento-de-las-tabletas-sph3127-un-nuevo-punto-de-referencia-para-la-innovacion-en-medicina-para-la-hipertension-en-china/ 2025-12-12T01:49:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/impacto-en-el-tratamiento-de-la-hipertension-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/nmap-aprobo-oficialmente-el-sph3127-en-tabletas.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion-de-sph3127.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/demanda-del-mercado-global.webp https://dengyuedistributor.com/noticias-medicas/nueva-estrella-en-la-lucha-contra-medicamento-para-la-gripe-el-avance-y-el-potencial-de-las-tabletas-de-sebaloxavir-marboxil/ 2025-12-10T07:48:28+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/sebaloxavir-marboxil.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/virus-de-la-gripe.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/mecanismo-de-accion.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/datos-de-investigacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20251117172954_207_39.webp https://dengyuedistributor.com/guias-medicas/prevencion-y-control-cientifico-del-cancer-de-cuello-uterino-una-guia-completa-desde-la-prevencion-y-las-prueba-del-h-hasta-la-gestion-de-la-salud/ 2025-12-09T07:40:33+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/cancer-de-cuello-uterino.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/vacunacion-contra-el-hpv.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/estilo-de-vida-saludable.webp https://dengyuedistributor.com/blog/el-proximo-farmaco-innovador-de-gran-exito-podria-provenir-de-china/ 2025-12-08T08:57:26+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/Datos-sobre-farmacos-innovadores.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/ich.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/Inteligencia-artificial.webp https://dengyuedistributor.com/noticias-medicas/nbp-butylphthalide-un-avance-en-la-neuroproteccion-para-la-isquemia/ 2025-12-05T09:45:16+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/datos-clinicos.webp https://dengyuedistributor.com/noticias-medicas/los-medicamentos-innovadores-de-china-se-encuentran-en-un-momento-critico-de-la-globalizacion/ 2025-12-04T07:38:48+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/the-economist.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/tres-fuerzas-impulsoras-de-los-avances-en-innovacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/12/un-camino-de-tres-pasos-hacia-la-innovacion-y-la-transformacion-1.webp https://dengyuedistributor.com/noticias-medicas/nmpa-aprueba-la-inyeccion-de-picankibart-para-su-comercializacion/ 2025-12-03T08:44:19+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/aprobo-oficialmente-la-inyeccion-de-Picankibart.png https://dengyuedistributor.com/wp-content/uploads/2025/12/dirigido-a-la-subunidad-IL-23p19-para-una-regulacion-precisa-de-la-respuesta-inmune.png https://dengyuedistributor.com/wp-content/uploads/2025/12/picankibart-Injection.png https://dengyuedistributor.com/wp-content/uploads/2025/12/psoriasis.png https://dengyuedistributor.com/blog/que-es-un-farmaco-innovador-explorando-el-futuro-de-la-medicina/ 2025-12-02T07:15:11+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/12/image.png https://dengyuedistributor.com/wp-content/uploads/2025/12/image-1.png https://dengyuedistributor.com/noticias-medicas/distribuidor-farmaceutico-de-china-redefiniendo-el-futuro-de-la-cadena-de-suministro-de-atencion-medica/ 2025-12-01T09:17:20+00:00 https://dengyuedistributor.com/noticias-medicas/que-tan-fuerte-es-la-industria-farmaceutica-innovadora-de-china-china-emerge-como-una-potencia-mundial-en-innovacion-farmaceutica/ 2025-12-01T09:13:36+00:00 https://dengyuedistributor.com/blog/como-importar-medicamentos-de-china-guia-completa-para-compradores-farmaceuticos-globales-2025/ 2025-12-01T08:53:51+00:00 https://dengyuedistributor.com/blog/los-100-principales-exportadores-farmaceuticos-de-china-como-china-se-convirtio-en-una-potencia-farmaceutica-mundial/ 2025-11-28T08:29:41+00:00 https://dengyuedistributor.com/blog/ventajas-clave-de-asociarse-con-los-principales-mayoristas-farmaceuticos-chinos-dengyuepharma/ 2025-11-26T07:04:32+00:00 https://dengyuedistributor.com/noticias-medicas/inyeccion-de-zanidatamab-ziihera-aprobada-en-china-para-el-cancer-de-vias-biliares-avanzado-con-her2-positivo/ 2025-11-26T09:00:00+00:00 https://dengyuedistributor.com/noticias-medicas/ltimas-noticias/china-ha-aprobado-inpegsomatropin-injection-para-mejorar-la-eficacia-de-la-terapia-con-hormona-del-crecimiento/ 2025-11-25T16:37:00+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-31.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-32.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-33.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-35.png https://dengyuedistributor.com/noticias-medicas/hympavzi-se-lanzo-el-anticuerpo-tfpi-un-nuevo-avance-en-el-tratamiento-de-la-hemofilia/ 2025-11-24T09:27:49+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/muy-esperado-farmaco-innovador-inyectable-marstacimab-hncq.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/especificamente-a-las-dianas-relacionadas-con-la-enfermedad.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/seguro-y-confiable-una-opcion-en-la-que-los-pacientes-pueden-confiar.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global.webp https://dengyuedistributor.com/blog/tendencias-que-influiran-en-la-distribucion-de-medicamentos-en-2025/ 2025-11-21T08:06:31+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/impulsada-por-el-crecimiento-de-la-demanda-del-mercado-global-y-la-transformacion-digital.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/digitalizacion-y-automatizacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/optimizacion-de-la-cadena-de-suministro-y-distribucion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/modelos-de-mercado-y-ajustes-regulatorios.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/enfoque-en-el-desarrollo-sostenible.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/Conclusion.webp https://dengyuedistributor.com/blog/tendencias-futuras-en-la-industria-de-franquicias-pcd-farmaceuticas/ 2025-11-20T08:57:35+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/la-industria-farmaceutica-es-uno-de-los-sectores-mas-competitivos-y-de-mayor-crecimiento-a-nivel-mundial.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/progreso-tecnologico-y-transformacion-digital.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/cambios-normativos-y-estandares-de-calidad.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/centrarse-en-medicamentos-especializados.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/ecosistema-colaborativo.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/hkdengyuepharma-1.webp https://dengyuedistributor.com/noticias-medicas/corporacion-de-exportacion-farmaceutica-de-china-dengyuepharma/ 2025-11-19T08:50:40+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/china-se-ha-convertido-en-un-centro-mundial-de-produccion-y-exportacion-farmaceutica.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/hkdengyuepharma-1.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/consultores-de-exportacion-farmaceutica.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/empresas-exportadoras-farmaceuticas-china.webp https://dengyuedistributor.com/guias-medicas/por-que-elegir-medicamentos-innovadores-china/ 2025-11-19T08:50:25+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/industria-farmaceutica-china-esta-experimentando-una-transformacion-historica.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/la-innovacion-impulsada-por-politicas-publicas-libera-el-potencial-del-mercado.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/avances-tecnologicos-transforman-la-competitividad-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global-de-los-farmacos-innovadores-china-continua.webp https://dengyuedistributor.com/guias-medicas/guia-de-seguridad-para-la-compra-de-medicamentos-en-linea/ 2025-11-17T09:14:44+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/que-todos-puedan-comprar-medicamentos-de-forma-segura.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/sistema-de-trazabilidad.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/revision-electronica-de-recetas.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/control-especial-de-medicamentos-1.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/verificacion-del-numero-de-autorizacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/tres-principios-para-la-compra-segura-de-medicamentos.webp https://dengyuedistributor.com/noticias-medicas/la-fda-ha-aprobado-el-primer-inhibidor-de-btk-del-mundo-los-comprimidos-de-remibrutinib/ 2025-11-17T03:47:17+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/fda.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/bloqueo-preciso-de-las-vias-inmunitarias.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/necesidad-urgente-de-los-pacientes.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/expansion-global.webp https://dengyuedistributor.com/noticias-medicas/los-datos-del-ensayo-clinico-de-fase-ii-de-guang-sheng-tang-gst-hg131-son-notables/ 2025-11-14T09:11:03+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/aasld.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/dirigirse-a-la-secrecion-de-hbsag-para-reiniciar-la-respuesta-inmunitaria.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/datos-de-la-fase-II.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/terapia-combinada.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/reconocimiento-internacional-y-perspectivas-de-industrializacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/DengYuePharma.webp https://dengyuedistributor.com/noticias-medicas/el-anticuerpo-monoclonal-anti-vegf-de-bio-thera-logra-un-gran-exito-en-el-ensayo-clinico-de-fase-iii/ 2025-11-13T08:10:43+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/desarrollado-de-forma-independiente.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/datos-clinicos-lideres-a-nivel-mundial.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/al-abordar-los-problemas-del-mercado-global.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/seguros-y-controlables-durante-todo-el-proceso.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/HKDengYuePharma.webp https://dengyuedistributor.com/blog/de-seguidor-a-lider-adquiriendo-los-mejores-medicamentos-chinos-innovadores-del-mundo/ 2025-11-12T10:01:48+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/China-esta-pasando-de-ser-seguidora-a-lider.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/innovacion-objetivo.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/estrategia-de-globalizacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/ventaja-en-costos.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/la-mision-global-de-los-farmacos-innovadores-chinos.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/image-25.png https://dengyuedistributor.com/noticias-medicas/nueva-esperanza-para-los-pacientes-una-interpretacion-en-profundidad-de-los-ultimos-avances-en-medicamentos-innovadores-de-china/ 2025-11-12T03:03:34+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/image-17.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-18.png https://dengyuedistributor.com/noticias-medicas/pcar-19b-ya-esta-disponible/ 2025-11-12T02:40:05+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/nmpa-2.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/hama.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/rompiendo-la-maldicion-de-la-tasa-de-supervivencia-del-30.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/blood.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/DengYuePharma.webp https://dengyuedistributor.com/noticias-medicas/busca-distribuidores-farmaceuticos-chinos-un-analisis-exhaustivo-de-los-recursos-del-canal-profesional/ 2025-11-07T10:01:41+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-26.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-27.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-28.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-29.png https://dengyuedistributor.com/guias-medicas/como-distinguir-los-medicamentos-chinos-autenticos-de-los-falsificados/ 2025-11-07T09:29:29+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/comienzo.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/formato-del-numero-de-aprobacion-de-identificacion.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/escaneo-del-codigo-de-trazabilidad.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/image-29.png https://dengyuedistributor.com/noticias-medicas/el-olgotrelvir-sodium-ha-sido-aprobado-para-su-comercializacion/ 2025-11-07T06:13:05+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_2025.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_30.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/DengYuePharma.webp https://dengyuedistributor.com/noticias-medicas/es-mas-conveniente-comprar-medicamentos-en-china-explicacion-detallada-del-proceso-precios-y-recomendaciones-de-medicamentos/ 2025-11-07T02:02:17+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-23.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-24.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-25.png https://dengyuedistributor.com/noticias-medicas/plataforma-de-cooperacion-para-la-distribucion-y-venta-mayorista-de-productos-farmaceuticos-en-china-ayudando-a-las-empresas-farmaceuticas-a-expandir-sus-mercados/ 2025-11-06T08:35:08+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-15.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-16.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-17.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-18.png https://dengyuedistributor.com/noticias-medicas/cooperacion-de-inversion-de-mayoristas-farmaceuticos-de-china-unase-a-la-red-nacional-de-suministro-farmaceutico/ 2025-11-05T09:29:48+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-11.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-12.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-13.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-14.png https://dengyuedistributor.com/noticias-medicas/los-hospitales-y-las-farmacias-prefieren-socios-mayoristas-de-medicamentos-de-hong-kong-suministro-estable-y-excelente-reputacion/ 2025-11-04T07:25:47+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-6.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-7.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-8.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-9.png https://dengyuedistributor.com/wp-content/uploads/2025/11/%E7%99%BB.webp https://dengyuedistributor.com/wp-content/uploads/2025/11/image-10.png https://dengyuedistributor.com/noticias-medicas/servicios-profesionales-de-distribucion-farmaceutica-china-gama-completa-de-medicamentos-y-entrega-rapida/ 2025-11-03T09:44:51+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-2.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-3.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-4.png https://dengyuedistributor.com/wp-content/uploads/2025/11/image-5.png https://dengyuedistributor.com/noticias-medicas/mayorista-lider-de-medicamentos-innovadores-en-china-su-socio-confiable-de-la-cadena-de-suministro-farmaceutico/ 2025-11-01T09:27:01+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image-1.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-16.png https://dengyuedistributor.com/noticias-medicas/el-socio-preferido-de-china-para-la-distribucion-innovadora-de-medicamentos-abrir-canales-y-maximizar-el-mercado/ 2025-11-01T09:16:48+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/11/image.png https://dengyuedistributor.com/wp-content/uploads/2025/10/%E9%A6%99%E6%B8%AF%E7%99%BB%E6%9C%88.webp https://dengyuedistributor.com/noticias-medicas/cooperacion-beneficiosa-para-todos-explorando-los-mejores-socios-y-modelos-para-la-innovadora-industria-farmaceutica-de-china/ 2025-10-31T10:00:45+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/%E9%A6%99%E6%B8%AF%E7%99%BB%E6%9C%88.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/image-12.png https://dengyuedistributor.com/uncategorized/mayorista-farmaceutico-chino-profesional-el-mejor-precio-y-una-cadena-de-suministro-sin-preocupaciones-todo-en-un-solo-paso/ 2025-10-30T09:54:25+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/image-13.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-14.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-15.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-16.png https://dengyuedistributor.com/noticias-medicas/mayorista-profesional-chino-de-importacion-y-exportacion-de-productos-farmaceuticos-comercio-compatible-acceso-global-su-eleccion-confiable/ 2025-10-30T02:16:47+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/image-9.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-10.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-11.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-12.png https://dengyuedistributor.com/uncategorized/suministro-farmaceutico-confiable-en-todo-el-mundo-el-socio-preferido-para-los-mayoristas-de-importacion-y-exportacion-en-china/ 2025-10-28T09:03:24+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/image-6.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-7.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-8.png https://dengyuedistributor.com/noticias-medicas/distribuidor-farmaceutico-de-confianza-en-hong-kong-su-experto-local-en-marketing-y-cumplimiento/ 2025-10-28T03:05:34+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/image-2.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-3.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-4.png https://dengyuedistributor.com/wp-content/uploads/2025/10/image-5.png https://dengyuedistributor.com/noticias-medicas/acelere-los-medicamentos-innovadores-en-el-extranjero-sea-el-motor-estrategico-de-su-diseno-global-y-gane-el-futuro/ 2025-10-27T08:56:09+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/%E5%9B%BE%E7%89%87.webp https://dengyuedistributor.com/noticias-medicas/investigacion-y-desarrollo-de-medicamentos-innovadores-de-china-liderando-la-nueva-ola-de-biomedicina-global/ 2025-10-27T02:44:49+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/cgi-bin_mmwebwx-bin_webwxgetmsgimg__MsgID5648542769367895468skey@crypt_d922369_44db6b6f9938d55b826f45be4d39f5c9mmweb_appidwx_webfilehelper_11zon.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/cgi-bin_mmwebwx-bin_webwxgetmsgimg__MsgID5265621990656197636skey@crypt_d922369_44db6b6f9938d55b826f45be4d39f5c9mmweb_appidwx_webfilehelper_11zon.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/image-1.png https://dengyuedistributor.com/noticias-medicas/las-diez-principales-transacciones-farmaceuticas-de-china-en-2025-escondiendo-un-mapa-del-futuro/ 2025-10-24T08:49:25+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/cgi-bin_mmwebwx-bin_webwxgetmsgimg__MsgID1474430544080947659skey@crypt_d922369_e062ac64a05fb0753f6b3e2a490dc4acmmweb_appidwx_webfilehelper_11zon.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/cgi-bin_mmwebwx-bin_webwxgetmsgimg__MsgID1956894254341659108skey@crypt_d922369_e062ac64a05fb0753f6b3e2a490dc4acmmweb_appidwx_webfilehelper_11zon.webp https://dengyuedistributor.com/noticias-medicas/como-una-droga-innovadora-de-china-se-convierte-en-el-superheroe-de-pacientes-con-enfermedades-raras/ 2025-10-23T07:23:35+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/%E5%9B%BD%E5%AE%B6%E7%9B%91%E7%AE%A1%E5%B1%80%E7%85%A7%E7%89%87.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/%E6%B3%95%E8%BF%BD.webp https://dengyuedistributor.com/wp-content/uploads/2025/10/%E9%A6%99%E6%B8%AF%E7%99%BB%E6%9C%88.webp https://dengyuedistributor.com/noticias-medicas/el-avance-manufacturero-de-china-se-globaliza/ 2025-10-22T07:53:33+00:00 https://dengyuedistributor.com/wp-content/uploads/2025/10/la-innovacion-farmaceutica-de-china-se-globaliza-entrar-y-romper-el-cerco.webp